Immune effects of interferon gamma in persistent staphylococcal sepsis.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  American Journal of Respiratory and Critical Care Medicine

• Publication date

  2012-12-14

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1164/AJRCCM.185.1.110PMID 22210794
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The post sepsis-induced expansion and enhanced function of regulatory T cells create an environment to potentiate tumor growth.

  2010cited by this paper
• Monocytic HLA‐DR expression in intensive care patients: Interest for prognosis and secondary infection prediction *

  2009cited by this paper
• Activities of Daptomycin and Comparative Antimicrobials, Singly and in Combination, against Extracellular and Intracellular Staphylococcus aureus and Its Stable Small-Colony Variant in Human Monocyte-Derived Macrophages and in Broth

  2008cited by this paper
• Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction.

  1999cited by this paper
• Small colony variants in staphylococcal infections: diagnostic and therapeutic implications.

  1998cited by this paper
• Interferon gamma-1b in the treatment of compensatory anti-inflammatory response syndrome. A new approach: proof of principle.

  1997cited by this paper
• Cellular responses to interferon-gamma.

  1997cited by this paper

• Challenges of monocyte HLA-DR targeted immunomodulation in sepsis—a prospective observational cohort study

  2026cites this paper
• Innate immunosenescence and sepsis in the elderly: mechanisms and innate immune modulation strategies

  2025cites this paper
• IFNγ in human sepsis: a scoping review

  2025cites this paper
• BCG‐Derived Outer Membrane Vesicles Induce TLR2‐Dependent Trained Immunity to Protect Against Polymicrobial Sepsis

  2025cites this paper
• Interferon gamma applied ex vivo restores function to neutrophils from critically ill patients

  2025cites this paper
• Attenuated interferon-γ following injury is associated with chronic critical illness.

  2025cites this paper
• Exploring the role of antioxidants in sepsis-associated oxidative stress: a comprehensive review

  2024cites this paper
• Immunoadjuvant therapy in the regulation of cell death in sepsis: recent advances and future directions

  2024cites this paper
• Sepsis in Aging Populations: A Review of Risk Factors, Diagnosis, and Management

  2024cites this paper
• Effect of chitosan nanogels loaded with vancomycin and gamma interferon on TNF-α gene expression in macrophage cell line activated with methicillin-resistant Staphylococcus aureus (MRSA)

  2024cites this paper
• The role of trained immunity in sepsis

  2024cites this paper
• Interferon-γ regulates immunosuppression in septic mice by promoting the Warburg effect through the PI3K/AKT/mTOR pathway

  2023cites this paper
• Changes in immune function and immunomodulatory treatments of septic patients.

  2022cites this paper
• Evaluating the effects of curcumin nanomicelles on clinical outcome and cellular immune responses in critically ill sepsis patients: A randomized, double-blind, and placebo-controlled trial

  2022cites this paper
• Opportunities for correction of immunosuppression in patients with COVID-19

  2022cites this paper
• Innate immune response to peritoneal bacterial infection.

  2022cites this paper
• Superantigens promote Staphylococcus aureus bloodstream infection by eliciting pathogenic interferon-gamma production

  2022cites this paper
• Immunophenotyping of Peripheral Blood Mononuclear Cells in Septic Shock Patients With High-Dimensional Flow Cytometry Analysis Reveals Two Subgroups With Differential Responses to Immunostimulant Drugs

  2021cites this paper
• Immunological Endotyping of Chronic Critical Illness After Severe Sepsis

  2021cites this paper
• Immune Cell Number, Phenotype, and Function in the Elderly with Sepsis

  2021cites this paper
• Sepsis-Induced Immunosuppression.

  2021cites this paper
• Useful and Promise Cellular Markers for Immunosuppression in Sepsis.

  2021cites this paper
• Superantigens promote Staphylococcus aureus bloodstream infection by eliciting pathogenic interferon-gamma (IFNγ) production that subverts macrophage function

  2021cites this paper
• The many faces of macrophages : polarization, endotoxin priming, and Salmonella resistance

  2020cites this paper
• Is there immune suppression in the critically ill patient - pro?

  2020cites this paper
• Myeloid cells in sepsis‐acquired immunodeficiency

  2020cites this paper
• Dental follicle mesenchymal stem cells regulate inflammatory responses in sepsis

  2020influential citation
• Crosstalk between Dendritic Cells and Immune Modulatory Agents against Sepsis

  2020cites this paper
• Classification of Patients With Sepsis According to Immune Cell Characteristics: A Bioinformatic Analysis of Two Cohort Studies

  2020cites this paper
• New biomarkers for respiratory infections.

  2020cites this paper
• LYMPHOCYTE IMMUNOSUPPRESSION AND DYSFUNCTION CONTRIBUTING TO PERSISTENT INFLAMMATION, IMMUNOSUPPRESSION, AND CATABOLISM SYNDROME (PICS)

  2020cites this paper
• Immune Pathogenesis of COVID-19 Intoxication: Storm or Silence?

  2020cites this paper
• Developing Novel Host-Based Therapies Targeting Microbicidal Responses in Macrophages and Neutrophils to Combat Bacterial Antimicrobial Resistance

  2020cites this paper
• Au-delà des études d'association à l'échelle du génome : étude transcriptomique et identification des variants régulateurs impliqués dans le développement du sepsis

  2019cites this paper
• New frontiers in precision medicine for sepsis-induced immunoparalysis

  2019cites this paper
• Actualités sur le sepsis et le choc septique de l’enfant

  2019cites this paper
• How Clinical Flow Cytometry Rebooted Sepsis Immunology

  2019cites this paper
• Pathological alteration and therapeutic implications of sepsis-induced immune cell apoptosis

  2019cites this paper
• Autophagy and proinflammatory cytokines: Interactions and clinical implications.

  2018cites this paper
• Management of Sepsis-Induced Immunosuppression.

  2018cites this paper
• Immunosuppression in sepsis and possibility of its correction

  2018cites this paper
• glucagon-like peptide-1 receptor (glP-1r) signaling ameliorates dysfunctional immunity in COPD patients

  2018cites this paper
• Innate Immunity in the Persistent Inflammation, Immunosuppression, and Catabolism Syndrome and Its Implications for Therapy

  2018cites this paper
• Immune Paralysis in Sepsis: Recent Insights and Future Development

  2018cites this paper
• Advances in the understanding and treatment of sepsis-induced immunosuppression

  2018cites this paper
• glucagon-like peptide-1 receptor (glP-1r) signaling ameliorates dysfunctional immunity in COPD patients

  2018cites this paper
• Иммуносупрессия при сепсисе и возможности ее коррекции

  2018cites this paper
• Sepsis and Nosocomial Infection: Patient Characteristics, Mechanisms, and Modulation

  2018cites this paper
• Glucagon-like peptide-1 receptor (GLP-1R) signaling ameliorates dysfunctional immunity in COPD patients

  2018cites this paper
• Precision Immunotherapy for Sepsis

  2018cites this paper
• Therapeutic effect of human ghrelin and growth hormone: Attenuation of immunosuppression in septic aged rats.

  2017cites this paper
• Sepsis-Induced Immune Suppression

  2017cites this paper
• Dynamics of Human Leukocyte Antigen-D Related expression in bacteremic sepsis

  2017cites this paper
• Immunomodulatory intervention with Gamma interferon in mice with sepsis

  2017cites this paper
• Potential Immunotherapeutics for Immunosuppression in Sepsis

  2017cites this paper
• T-cell Co-inhibitory Molecules in Sepsis-induced Immunosuppression: From Bench to Bedside

  2017cites this paper
• The immunopathology of sepsis and potential therapeutic targets

  2017cites this paper
• Diabetes and Sepsis: Risk, Recurrence, and Ruination

  2017cites this paper
• The immune system's role in sepsis progression, resolution, and long‐term outcome

  2016cites this paper
• Shikonin induces apoptosis of lung cancer cells via activation of FOXO3a/EGR1/SIRT1 signaling antagonized by p300.

  2016cites this paper
• Sepsis-induced immune dysfunction: can immune therapies reduce mortality?

  2016cites this paper
• Immunotherapy: A promising approach to reverse sepsis-induced immunosuppression.

  2016cites this paper
• Immunotherapy of Sepsis: Blind Alley or Call for Personalized Assessment?

  2016cites this paper
• CD1d- and MR1-Restricted T Cells in Sepsis

  2015cites this paper
• Tolerance and Cross-Tolerance following Toll-Like Receptor (TLR)-4 and -9 Activation Are Mediated by IRAK-M and Modulated by IL-7 in Murine Splenocytes

  2015cites this paper
• Severe sepsis Epidemiology and sex-related differences in inflammatory markers.

  2014cites this paper
• Sepsis: neue Erkenntnisse, andere Perspektiven – neue Therapieoptionen?

  2014cites this paper
• Analysis of Invariant Natural Killer T Cells in Intra-Abdominal Sepsis

  2014cites this paper
• [Is a different view on the pathophysiology of sepsis the key for novel therapeutic options?].

  2014cites this paper
• Should we be moving from suppression to stimulation to deal with immunoparalysis in sepsis patients?

  2014cites this paper
• Identification of Biomarkers of Response to IFNg during Endotoxin Tolerance: Application to Septic Shock

  2013cites this paper
• Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy

  2013cites this paper
• Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach.

  2013cites this paper
• Blockade ofthe negative co-stimulatory molecules PD-1 and CTLA-4 improves survival in primary and secondary fungal sepsis

  2013cites this paper